PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain.

Détails

Ressource 1Télécharger: 25884655_BIB_0B9AD1F6F80C.pdf (3035.12 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_0B9AD1F6F80C
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain.
Périodique
Bmc Neurology
Auteur⸱e⸱s
Spatola M., Wider C., Kuntzer T., Croquelois A.
ISSN
1471-2377 (Electronic)
ISSN-L
1471-2377
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
15
Pages
55
Langue
anglais
Notes
Publication types: Journal Article Publication Status: epublish
Résumé
BACKGROUND: LEOPARD syndrome (LS) belongs to the family of neuro-cardio-facio-cutaneous syndromes, which include Neurofibromatosis-1 (NF1), Noonan syndrome, Costello Syndrome, cardio-facio-cutaneous syndrome, Noonan-like syndrome with loose anagen hair and Legius syndrome. These conditions are caused by mutations in genes encoding proteins involved in the RAS-MAPK cellular pathway. Clinical heterogeneity and phenotype overlaps across those different syndromes is already recognized.
CASE PRESENTATION: We hereby report a heterozygous de novo mutation in the PTPN11 gene (c.1403C > T) manifesting with a clinical picture of LS during childhood, and later development of neuropathic pain with hypertrophic plexi, which are typically observed in NF1 but have not been reported in LS.
CONCLUSION: LS caused by PTPN11 mutations may be associated with hypertrophic roots and plexi. Consequently, clinicians should be aware of the possible development of neuropathic pain and consider specific diagnostic work-up and management.
Pubmed
Web of science
Open Access
Oui
Création de la notice
18/05/2015 16:56
Dernière modification de la notice
20/08/2019 13:33
Données d'usage